Combination product
Pronunciation: pi-PER-a-sil-in and ta-zoe-BAK-tam
Combination of Piperacillin and Tazobactam.
Each component keeps its own pharmacology page; the combination itself adds no new mechanism.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Infections other than nosocomial pneumonia (intra-abdominal, skin/skin structure, female pelvic, community-acquired pneumonia) | adults | 3.375 g IV every 6 hours | 3.375 g q6h (13.5 g/day) | 13.5 g/day |
| Nosocomial pneumonia | adults | 4.5 g IV every 6 hours plus an aminoglycoside | 4.5 g q6h (18 g/day) + aminoglycoside | 18 g/day |
| Intra-abdominal infections / nosocomial pneumonia | pediatric ≥2 months (up to 40 kg) | 2–9 mo: 90 mg/kg q8h (pneumonia q6h); >9 mo: 112.5 mg/kg q8h (pneumonia q6h) | weight-based per age/indication | do not exceed adult dose |
Renal CrCl ≤40 mL/min and dialysis patients: reduce dose per degree of renal impairment.
Hepatic No dosage adjustment in hepatic cirrhosis.
Available strengths
Pregnancy Insufficient human data; crosses the placenta; animal fetotoxicity seen with maternal toxicity.
Lactation Undefined
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 2.25 g | inj | per unit | not offered | |
| 3.375 g | inj | per unit | $3.49/ea | not offered |
| 4.5 g | inj | per unit | not offered |
Part D rank #284.